These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9851117)

  • 1. [*5q--syndrome].
    Yahata N; Ohyashiki K
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):187-90. PubMed ID: 9851117
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint.
    Boultwood J; Fidler C; Lewis S; Kelly S; Sheridan H; Littlewood TJ; Buckle VJ; Wainscoat JS
    Genomics; 1994 Feb; 19(3):425-32. PubMed ID: 8188284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Refractory anemia: the entity and recent findings].
    Shimamoto T; Ohyashiki K
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):183-6. PubMed ID: 9851116
    [No Abstract]   [Full Text] [Related]  

  • 4. Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
    Pellagatti A; Cazzola M; Giagounidis A; Perry J; Malcovati L; Della Porta MG; Jädersten M; Killick S; Vyas P; Hellström-Lindberg E; Wainscoat JS; Boultwood J
    Br J Haematol; 2011 Oct; 155(2):272-4. PubMed ID: 21492127
    [No Abstract]   [Full Text] [Related]  

  • 5. 5q- and disordered haematopoiesis.
    Bunn HF
    Clin Haematol; 1986 Nov; 15(4):1023-35. PubMed ID: 3552346
    [No Abstract]   [Full Text] [Related]  

  • 6. [5q anomaly in myelodysplasia and acute myelocytic leukemia].
    Robak T
    Acta Haematol Pol; 1990; 21(2):235-42. PubMed ID: 2151871
    [No Abstract]   [Full Text] [Related]  

  • 7. Dihydrofolate reductase activity in the erythroblasts of patients with 5q- syndrome.
    Nano R; Invernizzi R; Pecci A; Civallero M; Gerzeli G
    Haematologica; 2000 Jul; 85(7):765-6. PubMed ID: 10897132
    [No Abstract]   [Full Text] [Related]  

  • 8. Late appearing 5q--marker in refractory anemia.
    Heim S; Billström R; Kristoffersson U; Mandahl N; Mitelman F
    Cancer Genet Cytogenet; 1987 Jan; 24(1):159-62. PubMed ID: 3466668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for 5q- occurring during the course of refractory anemia?
    Swansbury GJ
    Cancer Genet Cytogenet; 1987 Oct; 28(2):375. PubMed ID: 3621144
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of lenalidomide in the management of myelodysplasia with del 5q.
    Kelaidi C; Eclache V; Fenaux P
    Br J Haematol; 2008 Feb; 140(3):267-78. PubMed ID: 18217896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High resolution analysis of the 5q-marker chromosome in refractory anemia.
    Mitelman F; Manolova Y; Manolov G; Billström R; Heim S; Kristoffersson U; Mandahl N
    Hereditas; 1986; 105(1):49-54. PubMed ID: 3793519
    [No Abstract]   [Full Text] [Related]  

  • 12. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.
    Willman CL; Sever CE; Pallavicini MG; Harada H; Tanaka N; Slovak ML; Yamamoto H; Harada K; Meeker TC; List AF
    Science; 1993 Feb; 259(5097):968-71. PubMed ID: 8438156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
    Boultwood J; Pellagatti A; Cattan H; Lawrie CH; Giagounidis A; Malcovati L; Della Porta MG; Jädersten M; Killick S; Fidler C; Cazzola M; Hellström-Lindberg E; Wainscoat JS
    Br J Haematol; 2007 Nov; 139(4):578-89. PubMed ID: 17916100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology case of the month. Elderly woman with fatigue. The 5q- Syndrome.
    Wellman G; Veillon DM; Nordberg ML; Young RL; Cotelingam JD
    J La State Med Soc; 2002; 154(4):175-7. PubMed ID: 12236399
    [No Abstract]   [Full Text] [Related]  

  • 15. Absence of loss of heterozygosity of the IRF1 gene in some patients with a 5q31 deletion.
    Kroef MJ; Bolk MW; Willemze R; Landegent JE
    Blood; 1994 Apr; 83(8):2382. PubMed ID: 8161805
    [No Abstract]   [Full Text] [Related]  

  • 16. Clonal evolution in a transforming 5q- syndrome.
    Kandioler D; Krieger O; Nowotny H; Lutz D
    Leukemia; 1994 Apr; 8(4):711-2. PubMed ID: 8152269
    [No Abstract]   [Full Text] [Related]  

  • 17. Van-den Berghe's 5q- syndrome in 2008.
    Mohamedali A; Mufti GJ
    Br J Haematol; 2009 Jan; 144(2):157-68. PubMed ID: 19016715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription mapping of the 5q- syndrome critical region: cloning of two novel genes and sequencing, expression, and mapping of a further six novel cDNAs.
    Boultwood J; Fidler C; Strickson AJ; Watkins F; Kostrzewa M; Jaju RJ; Müller U; Wainscoat JS
    Genomics; 2000 May; 66(1):26-34. PubMed ID: 10843801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
    Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
    Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Deletion of the long arm of chromosome 5 in patients with hematologic malignancies].
    Brezinová J; Zemanová Z; Michalová K
    Cas Lek Cesk; 2001 Feb; 140(2):43-6. PubMed ID: 11262906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.